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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
equipment may indiĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ ? ? 
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and receive a result coulĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
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child passes the screening, the percentage of false negatives is 
1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
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Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisatio 
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3 Population and Healthcare Overview 
The population of Finland is 5,511,303 (World Bank, 2018a) and a birth rate estimated at 
9.6 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Finland had a reported population density of 18.1 people per square kilometre in 2017 and 
this has risen from 14.7 people per square kilometre in 1961 (World Bank, 2018c). In terms 
of healthcare facilities, the total density of hospitals in 2013 was 1.38 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 1.9 deaths/1,000 live 
births in total (World Bank, 2018d). 
The average life expectancy in Finland is estimated at 82 years (World Bank, 2018e), with a 
death rate 9.8 deaths/1,000 population in 2016 (World Bank, 2018f). Finland has a gross 
national income per capita (PPP int. $, 2013) of $38,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $3,701 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 9.7% (WHO, 2016b). 
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Figure 1: Total Population and Birth Rate in Finland 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
In Finland, there are national guidelines for conducting vision screening, however, it is 
organised regionally with differences between protocols. Vision screening is embedded into 
a general preventative child healthcare screening system and funded by each municipality. 
The National Institute of Health and Welfare develops and recommends the content of 
vision screening programme. Any revisions to the programme would be made by the 
National Institute of Health and Welfare in collaboration with a network of specialists, and 
funded by the government. It is not known when the programme started, or if there have 
been any changes since its implementation.  
There are no methods for quality monitoring imposed by the government and no research 
of concerning the vision screening programme.  
Vision screening is conducted by either an ophthalmologist, general practitioner (GP), youth 
doctor, or specialist nurse. The number of these professionals employed in vision screening 
per million population is unknown. There are no other general healthcare professionals that 
have been identified who could undertake the screening with additional training. There is no 
specific training provided in order to conduct vision screening. Ophthalmologists are the 
only professionals that prescribe glasses to children under the age of 8 years. Other 
treatment options for amblyopia include patching. All eligible children are offered 
treatment. 
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5 Screening programme  
The target conditions screened for by vision screening are retinopathy of prematurity (ROP) 
and amblyopia. The health care professionals delivering vision screening, venue for 
screening and tests used, vary depending on the age of the child. Specific details of the 
screening offered within each age group are described more fully in sections 5.1 to 5.4 
below. 
5.1 Vision screening - Preterm babies 
Preterm babies, if born under 32 weeks, are screened by an ophthalmologist at a hospital. 
The tests conducted at this age include eye inspection and retinal examination.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician before 
discharge, and then by a youth doctor or GP in a child welfare clinic. The tests conducted at 
this age include eye inspection, red reflex testing, pursuit movements and pupillary reflexes 
and presence or absence of eye contact. These tests are all conducted at birth. It is not 
known how many abnormal or inconclusive test results necessitate referral for further 
diagnostic examination. Criteria that necessitate referral include presence of abnormal eye 
structures, dark red reflex, or no eye contact.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened twelve times by a specialist nurse and four times 
by a GP in a child welfare clinic. The tests conducted at this age include eye inspection, 
fixation, red reflex testing, eye motility, cover test, Hirschberg test and pursuit movements. 
These tests are conducted at 4, 8 and 18 months. Criteria that necessitate referral include 
presence of abnormal eye structures, dark red reflex, or no eye contact. Infants are referred 
for further diagnostic examination after one abnormal or two inconclusive test results. 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years of age are screened by a specialist nurse or a GP in a 
child welfare clinic. This is part of routine visual screening conducted as a part of child 
welfare clinic visit. The tests conducted at this age include eye inspection, fixation, red reflex 
testing, eye motility, Hirschberg test, pursuit movement, pupillary reflexes, cover test, 
alternating cover test and visual acuity measurement. The age of screening and tests at each 
age are as follows:  
 
Ɣ 3 years: Eye inspection, fixation, red reflex testing, eye motility, Hirschberg test, 
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pursuit movements, pupillary reflexes, near visual acuity measurement.  
Ɣ 4 years: near and distance visual acuity, Hirschberg test, cover test, alternating cover 
test. This is repeated at the age of 5 years and 6 years.  
Ɣ 7 years: near and distance visual acuity. This is repeated at 11 years and 14 years of 
age.  
 
The optotype charts used for children aged 3 to 6 years include linear Lea Symbols based on 
the Snellen format (Snellen 6/126 to 6/3, logMAR 1.3 to -0.3, decimal 0.05 to 2.0) and a 
Snellen number chart at age 7 years and older. Children are referred for further diagnostic 
examination after one abnormal or two inconclusive test results 
 
The referral criteria are as follows: 
 
භ 3 to 4 years: strabismus, visual acuity under 0.5 decimal (6/12 Snellen, 0.3 logMAR) 
or 2 lines difference in visual acuity, absent red reflex, abnormal head posture.  
  
භ 5 to 6 years: strabismus, visual acuity under 0.63 decimal (6/9.5 Snellen, 0.2 logMAR) 
or 2 lines difference in visual acuity, absent red reflex, abnormal head posture. 
 
භ 7 years or older: distance visual acuity under 0.8 decimal (6/7.5 Snellen, 0.1 
logMAR), near visual acuity under 0.63 decimal ( 6/9.5 Snellen, 0.2 logMAR), or any 
symptomatic eye disorder 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Specialist Nurse Youth Doctor  GP 
Preterm babies  × 9 × × × 
0 to 3 months  9 × × 9 9 
3 to 36 months  × × 9 × 9 
3 to 7 years  × × 9 × 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
EI Fix RR EM Hir RE PM PR VA CT ACT 
Preterm babies  9 × × × × 9 × × × × × 
0 to 3 months  9 × 9 × × × 9 9 × × × 
3 to 36 months  9 9 9 9 9 × 9 × × 9 × 
3 to 7 years  9 9 9 9 9 × 9 9 9 9 9 
 
Key: EI: Eye Inspection; Fix: Fixation; RR: Red Reflex Testing; EM: Eye Motility; Hir: Hirschberg; RE: Retinal Exam; PM: Pursuit Movements; PR: 
Pupillary Reflexes; VA: Visual Acuity; CT: Cover Test; ACT: Alternating cover test 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Child Welfare Clinic 
Preterm babies  9 × 
0 to 3 months  × 9 
3 to 36 months  × 9 
3 to 7 years  × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used 
to detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated screening is routinely conducted in Finland.  
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7 Provision for Visually Impaired  
All children with visual impairments and their families have the right to get appropriate 
rehabilitation. There is one specialised school for blind and visually impaired children, this is 
owned and run by the government. It delivers teaching consultation, supportive materials 
and methods to the whole country. There is also boarding school, the number of pupils that 
attend this is not known. The costs per child for these schools is not known.  
Visually impaired children who attend regular mainstream primary schools are provided 
with special support which includes visual aids, glasses, magnifiers, reading devices and 
audio books.  
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8 Knowledge of existing screening programme 
The following data is provided by the National Institute of Health and Welfare Registries. 
The figures provided constitute the average number of patients treated in specialised care 
per year (between 2010 and 2017) who are under 18 years of age and another population  
under 12 years old. 
8.1 Prevalence/Diagnosis  
The prevalence of amblyopia and types of amblyopia in Finland is unknown. It is estimated 
that the prevalence of anophthalmia is 1.9/10,000 people, congenital cataract is 2.7/10,000 
people and congenital glaucoma is 0.6/10,000 people.  
8.2 Coverage 
Routine visual screening is conducted as part of the child welfare clinic visit. All children are invited 
for these visits and they are free of charge. Prior to this, the parents can make an appointment if 
they have any parental concerns about their chiůĚ ?ƐǀŝƐŝŽŶ ? 
8.3 Treatment success 
Estimated figures concerning the number of patients treated for congenital cataract, 
strabismus and amblyopia per year are:  
Ɣ Figures from Population under 18-years old (average per year from 8 years of data 
2010-2017):  
o Congenital cataract 627  
o Strabismus 12,722  
o Amblyopia 4,978 
  
Ɣ Figures from Population under 12-years old (average per year from 8 years of data 
2010-2017)  
o Congenital cataract 578  
o Strabismus 11,726  
o Amblyopia 4,848 
 
No further data available.  
8.4 Screening evaluation 
There is no data available concerning attendance, false negative referrals, false positive 
ƌĞĨĞƌƌĂůƐ ? ƚŚĞ ƉŽƐŝƚŝǀĞ ƉƌĞĚŝĐƚŝǀĞ ǀĂůƵĞ ? ƐĞŶƐŝƚŝǀŝƚǇ Žƌ ƐƉĞĐŝĨŝĐŝƚǇ ŽĨ Ă  ?ƌĞĨĞƌ ? ƌĞƐƵůƚ ĨƌŽŵ
screening.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
Routine visual screening is conducted as a part of child welfare clinic visit. Reference costs of 
the service provider from year 2011 is 50 Euros per visit to a specialized nurse, 104 Euros for 
a GP. Routine visual screening is conducted as a part of child welfare clinic visit, which is free 
of charge for the child and family (Kapiainen, Väisänen & Haula, 2014). 
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia including follow up:  
x Per visit to an ophthalmologist (3 to 10 visits needed) - 212 Euros per visit = 636 
Euros  ? 2,120 Euros total (Kapiainen, Väisänen & Haula, 2014). 
Ɣ User charges applies for visit to specialized health care, maximum of 41.20 Euros per 
visit (Kapiainen, Väisänen & Haula, 2014). 
Ɣ Patching: not known  
Ɣ Glasses 70 to 100 Euros per year for 2 to 5 years 
9.3 Cost of Treatment for strabismus  
Conservative treatment costs are the same as treatment for amblyopia. Reference cost for 
strabismus surgery 2,215.70 Euros ((Kapiainen, Väisänen & Haula, 2014). 
9.4 Cost of treatment for cataract 
Reference cost for cataract surgery 3,105.20 Euros in 2011 (Kapiainen, Väisänen & Haula, 
2014). User charges applies for visit to specialized health care, maximum of 41.20 Euros per 
visit (Kapiainen, Väisänen & Haula, 2014). The maximum charge for day surgery is 135.10 
Euros and charge for inpatient care is a maximum of 48.90 Euros per day (maximum 7 days 
per year for children less than 18 years of age). For children, 40% of costs of medication is 
reimbursed - excluding glaucoma for which 100% is reimbursed and only a user charge of 
4.50 Euros per purchase (Kapiainen, Väisänen & Haula, 2014). 
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